lyon
Rhône Alpes
BliNK Biomedical
specializes in the discovery and development of novel therapeutic antibodies for the treatment of cancer... Read moreBliNK Biomedical
specializes in the discovery and development of novel therapeutic antibodies for the treatment of cancer... Read moreNews
Jul 15, 2019
BioPortfolio
BliNK Biomedical: . Genmab Partners on Cancer Antibodies with BliNK Biomedical Launches $503M U.S. IPO httpow.lyEPBC50v0VtFÂpic.twitter.combNqBikXyfb
Jul 12, 2019
GlobeNewswire
Press Release: BliNK Biomedical : Genmab and BliNK Biomedical Enter into Commercial License Agreement
Sep 28, 2018
BioPortfolio
BliNK Biomedical: BliNK Biomedical SAS Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 12092018 Prices from USD $250
Jul 11, 2016
BioSpace
BliNK Biomedical: <b>BliNK Biomedical</b> Announces Close Of Series A Funding
BliNK Biomedical Competitors
1
2
3
4
5
6
7
8
9
10